Susquehanna International Group
INFI

Susquehanna International Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Susquehanna International Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-36,000
Closed -$7.56K – 13369
2023
Q2 		$7.56K Buy
36,000
+100
+0.3% +$17 ﹤0.01% 11795
2023
Q1 		$5.74K Sell
35,900
-53,100
-60% -$23.6K ﹤0.01% 12290
2022
Q4 		$49.8K Sell
89,000
-75,500
-46% -$64.2K ﹤0.01% 11399
2022
Q3 		$196K Buy
164,500
+39,900
+32% +$43K ﹤0.01% 10874
2022
Q2 		$78K Buy
124,600
+1,100
+0.9% +$844 ﹤0.01% 11695
2022
Q1 		$141K Sell
123,500
-261,600
-68% -$313K ﹤0.01% 11616
2021
Q4 		$866K Sell
385,100
-159,100
-29% -$399K ﹤0.01% 7673
2021
Q3 		$1.86M Buy
544,200
+399,700
+277% +$1.23M ﹤0.01% 5986
2021
Q2 		$432K Buy
144,500
+53,300
+58% +$169K ﹤0.01% 9935
2021
Q1 		$295K Buy
91,200
+48,200
+112% +$161K ﹤0.01% 10635
2020
Q4 		$91K Buy
+43,000
New +$70.9K ﹤0.01% 10541
2019
Q4 		– Sell
-22,400
Closed -$23K – 10896
2019
Q3 		$23K Buy
22,400
+2,200
+11% +$3K ﹤0.01% 9934
2019
Q2 		$36K Sell
20,200
-1,600
-7% -$2.58K ﹤0.01% 9908
2019
Q1 		$41K Sell
21,800
-79,400
-78% -$116K ﹤0.01% 8502
2018
Q4 		$119K Sell
101,200
-43,400
-30% -$78.1K ﹤0.01% 8124
2018
Q3 		$392K Buy
144,600
+20,100
+16% +$41.6K ﹤0.01% 6958
2018
Q2 		$238K Buy
124,500
+101,700
+446% +$205K ﹤0.01% 8285
2018
Q1 		$48K Buy
+22,800
New +$48.9K ﹤0.01% 8964
2017
Q3 		– Sell
-32,700
Closed -$51K – 9841
2017
Q2 		$51K Sell
32,700
-35,000
-52% -$67.5K ﹤0.01% 8886
2017
Q1 		$219K Buy
67,700
+50,900
+303% +$125K ﹤0.01% 7873
2016
Q4 		$23K Sell
16,800
-27,600
-62% -$36K ﹤0.01% 9417
2016
Q3 		$69K Sell
44,400
-10,800
-20% -$16.6K ﹤0.01% 8051
2016
Q2 		$73K Buy
+55,200
New +$258K ﹤0.01% 8152
2016
Q1 		– Sell
-98,700
Closed -$775K – 9848
2015
Q4 		$775K Sell
98,700
-12,700
-11% -$109K ﹤0.01% 5936
2015
Q3 		$941K Sell
111,400
-2,500
-2% -$23.1K ﹤0.01% 5876
2015
Q2 		$1.25M Sell
113,900
-5,700
-5% -$73.2K ﹤0.01% 5728
2015
Q1 		$1.67M Sell
119,600
-131,800
-52% -$2.02M ﹤0.01% 4668
2014
Q4 		$4.25M Buy
251,400
+53,800
+27% +$783K ﹤0.01% 3126
2014
Q3 		$2.65M Buy
197,600
+60,200
+44% +$717K ﹤0.01% 4113
2014
Q2 		$1.75M Buy
137,400
+24,000
+21% +$250K ﹤0.01% 4907
2014
Q1 		$1.35M Sell
113,400
-140,400
-55% -$1.88M ﹤0.01% 4988
2013
Q4 		$3.5M Buy
253,800
+102,100
+67% +$1.44M ﹤0.01% 3425
2013
Q3 		$2.65M Buy
151,700
+8,100
+6% +$155K ﹤0.01% 3668
2013
Q2 		$2.33M Buy
+143,600
New +$4.44M ﹤0.01% 3667

Other funds holding INFI

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Susquehanna International Group's INFI Position: Q3 2023 in Review

Susquehanna International Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 11,008 shares — an estimated $2.32K sold.

Susquehanna International Group first reported a position in INFI in Q2 2013 and held it in 35 quarters. The position peaked at $7.53M in Q4 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Susquehanna International Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 11,008 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $2.32K.
  • Susquehanna International Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 35 quarters.
  • Susquehanna International Group's Infinity Pharmaceuticals, Inc. position peaked at $7.53M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.